Novel Compounds as TREM2 Agonists for Treating Alzheimer’s Disease
Provided herein are novel compounds as TREM2 agonists, pharmaceutical compositions, use of such compounds in treating Alzheimer's disease, and processes for preparing such compounds.
Authors
- Ram W. Sabnis (ORCID: https://orcid.org/0000-0001-7289-0581)
- Anika R. Sabnis (ORCID: https://orcid.org/0009-0008-9940-6583)
Institutions
- Mayo Clinic (US)
Publication Details
- Journal
- ACS Medicinal Chemistry Letters
- Published
- 2025-12-27
- DOI
- https://doi.org/10.1021/acsmedchemlett.5c00751
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00